Source comparison
BPC-157 vs Conventional Gut Healing Protocols: Mechanism Comparison
BPC-157 Peptide VEGF upregulation, angiogenesis, tight junction stabilisation 7–14 days for measurable healing Animal studies show 60–88% faster ulcer closure vs controls Strongest evidence for direct tissue regeneration. Limited human trial data Proton Pump I
This comparison does not assign a generated winner or score.
- BPC-157 Peptide
- VEGF upregulation, angiogenesis, tight junction stabilisation
- 7–14 days for measurable healing
- Animal studies show 60–88% faster ulcer closure vs controls
- Strongest evidence for direct tissue regeneration. Limited human trial data
- Proton Pump Inhibitors (PPIs)
- Gastric acid suppression via H+/K+ ATPase inhibition
- 4–8 weeks for symptomatic relief
- Reduces acid-mediated damage but does not accelerate mucosal repair
- Symptom control only. Does not address barrier dysfunction or angiogenesis
- L-Glutamine Supplementation
- Provides fuel for enterocyte turnover
- 4–12 weeks for measurable permeability reduction
- Some evidence for reduced intestinal permeability in critical illness
- Supports normal turnover. No evidence for accelerated regeneration in chronic damage
- Probiotics (Multi-Strain)
- Modulates gut microbiome, reduces inflammatory cytokines
- 8–12 weeks for symptom improvement
- Limited evidence for structural mucosal repair
- Immune modulation and symptom relief. Indirect tissue effects
- Collagen Peptides
- Provides amino acids for connective tissue synthesis
- 6–12 weeks for permeability improvement
- Weak evidence for gut-specific barrier repair
- Supports general tissue turnover. No targeted growth factor activation